ReviewInternational journal of clinical and experimental pathology2025
Epidemiology and patterns of GI tract cancers in Saudi Arabia: benefit of prompt lifestyle changes.
Review in International journal of clinical and experimental pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Awareness and Knowledge of Gastric Cancer in the General Population of Jeddah, Saudi Arabia: A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026Article
- Awareness of colorectal cancer and screening uptake in Eastern KSA: Predictors and implications.Journal of Taibah University Medical Sciences · 2026Article
- Epidemiological and histopathological spectrum of gastrointestinal tract disorders: a decade of records from the UAE.BMC gastroenterology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe economic prosperity experienced by Saudi Arabia in recent decades has had significant effects on the epidemiology and patterns of numerous non-communicable diseases, including cancer. The risk factors that often accompany financial prosperity include adopting a western diet, lack of physical activity, and a sedentary lifestyle. These factors contribute to an increased prevalence of chronic diseases andcan gradually increase the risk of gastrointestinal cancers. Therefore, the purpose of this review was to investigate the effect of embracing a western lifestyle on the epidemiology and patterns of gastrointestinal cancers in Saudi Arabia.
methodsI gathered information from various sources in Saudi Arabia regarding the incidence, rate, contributing factors , and other epidemiologic measurements of gastrointestinal cancer. I utilized a range of electronic search platforms, encompassing PubMed, Web of Science, Scopus, Google Scholar, and other electronic databases that met the specified criteria. I also made use of the Global Cancer Observatory and the Global Health Observatory databases.
resultsThe incidence of gastrointestinal cancers significantly rose during this period of prosperity. Colorectal cancer had the highest incidence, while liver cancer had the highest mortality rate. There has been a significant rise in various risk factors for gastrointestinal issues, especially physical inactivity, obesity, diabetes, and infections such as hepatitis and Helicobacter pylori (
conclusionAlthough data on gastrointestinal cancers in Saudi Arabia are limited, there are notably high epidemiological rates, particularly for colorectal, liver, and stomach cancers. A range of risk factors have been linked to the emergence of gastrointestinal cancers, likely due to recent changes in lifestyle in Saudi Arabia, especially the embrace of western habits. The most common risk factors include dietary influences, obesity, and infections. Intervention at both the policymaker and community levels is critical.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.